Trending...
- Future Intelligence Think Tank Surpasses 1,000 Members Exploring Human and Artificial Intelligence
- Tacoma: Applicants Sought for the Audit Advisory Board
- Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)
~ In a groundbreaking move, the Tacoma City Council has passed Resolution 41609, declaring entheogen-related activities as the lowest law enforcement priority within the city. The resolution, which was brought forward by District 5 Council Member Joe Bushnell and co-sponsored by Mayor Victoria Woodards, At-large Council Member Olgy Diaz, and District 3 Council Member Jamika Scott, aims to open doors for mental health treatment research by decriminalizing entheogens.
Council Member Bushnell, a veteran who lives with PTSD, emphasized the importance of exploring innovative and compassionate approaches to mental health. He stated that in the United States alone, 22 veterans commit suicide every day and as someone who understands the challenges of living with a mental health condition, he sees the potential of entheogens as a beacon of hope. By declaring support for decriminalization, Tacoma can advocate for further research and potentially life-changing treatments.
More on Washingtoner
Entheogens have been scientifically proven to be effective in treating various conditions such as depression, anxiety, addiction, and PTSD. In fact, the FDA has designated psilocybin-assisted therapy as a breakthrough treatment for treatment-resistant depression.
Tacoma now joins other Washington state jurisdictions such as Seattle, Port Townsend, Olympia, and Jefferson County in deprioritizing local enforcement against entheogen-related activities. This move reflects a growing trend towards recognizing the potential benefits of these substances in treating mental health conditions.
The passing of Resolution 41609 is seen as a significant step towards promoting more progressive and compassionate approaches to mental health treatment in Tacoma. With this resolution in place, it is hoped that further research will be conducted on entheogens and their potential therapeutic uses.
Council Member Bushnell, a veteran who lives with PTSD, emphasized the importance of exploring innovative and compassionate approaches to mental health. He stated that in the United States alone, 22 veterans commit suicide every day and as someone who understands the challenges of living with a mental health condition, he sees the potential of entheogens as a beacon of hope. By declaring support for decriminalization, Tacoma can advocate for further research and potentially life-changing treatments.
More on Washingtoner
- Solid Earth's new "Welcome to Real Estate" campaign introduces RealtyID™: Know Before Your Open the Door
- Radio Drive's New Album Walk With Me Delivers Two GRAMMY® Submissions Across Rock and Alternative Categories
- Kaplan Morrell and Attorney Jacqui Condon Selected to Represent Professional Women's Soccer Players in Workers' Compensation Matters
- ClearSight Therapeutics Receives NIH SBIR Phase I Award for Conjunctivitis and EKC Research
- Lunai Bioworks (N A S D A Q: LNAI) Takes Parkinson's Discovery to the Next Level With Exclusive Tanaist Agreement
Entheogens have been scientifically proven to be effective in treating various conditions such as depression, anxiety, addiction, and PTSD. In fact, the FDA has designated psilocybin-assisted therapy as a breakthrough treatment for treatment-resistant depression.
Tacoma now joins other Washington state jurisdictions such as Seattle, Port Townsend, Olympia, and Jefferson County in deprioritizing local enforcement against entheogen-related activities. This move reflects a growing trend towards recognizing the potential benefits of these substances in treating mental health conditions.
The passing of Resolution 41609 is seen as a significant step towards promoting more progressive and compassionate approaches to mental health treatment in Tacoma. With this resolution in place, it is hoped that further research will be conducted on entheogens and their potential therapeutic uses.
0 Comments
Latest on Washingtoner
- Visit London Appoints The SEO Works for AI-First Search Strategy
- Spokane: Parks & Recreation Secures Top Ranking for $4.6M in State Grant Match
- City of Spokane to Install First 'Emergency Streets' Lane Closure After Weekend Fatal Crash
- Inglewood Associates and Gordon Brothers Provide Update on Sale Process for 925 Euclid Avenue in Cleveland
- Century Fasteners Corp. Exhibiting at the 2026 International Fastener Expo
- Las Vegas Attorney Thomas Boley Publishes Free Plain-English Guide to 100 Nevada Criminal Laws, in English and Spanish
- Tacoma: 'Preparing the Bid' Workshop on October 19
- Tacoma: Street Operations Crew Scheduled to Conduct Snow and Ice Training October 12 – 14
- Bank Statement Loans Up to $30 Million: Lendmire Announces High-Net-Worth Financing
- Guberman to Business Owners, Implant Patients: Your ISO 9001,ISO 13485 AS9100,AI9100 Certificate Is Dead, and Nobody Knows What's Inside You
- NYC Big Book Award Celebrates 10th Anniversary with Announcement of 2026 Winners
- Squaawke Releases a Hymn-Cycle Written for Intelligent Machines
- Tickeron Launches New AI Trading Robots for Semi & Finance with Profit Factor 2.8 for Hedge Funds (JPM, BAC, NVDA, GOOG, AVGO, META, AMD)
- Regional Magazines Shine at IRMA Awards
- Spokane: Impacts For Final Stretch of Construction Season
- Kocer Consulting & Engineering's Dan Kocer Named 2026 PNAA Chair Award Recipient
- Matt Zavala of Zavala Law, PC Selected to the 2027 Super Lawyers List
- Sawgrass Ford President Attributes Dealerships Success to Long-Term Employees
- Ragin' Cajun Announces New Cheeseburger Seasoning on National Cheeseburger Day
- Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB)